Please enable Javascript
Michel Zwaan, MD, PhD
Articles by Michel Zwaan, MD, PhD
Michel Zwaan, MD, PhD: 'Clear Medical Need’ in KMT2Ar Pediatric Acute Leukemias
Michel Zwaan, MD, PhD
Acute Lymphoblastic Leukemia
|
April 22, 2024
A phase II study presented at ASPHO 2024 evaluated revumenib in KMT2A-rearranged ALL and AML.
View More